Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

- Read more about Nepal seized Dabur products due to expiry dates issue
Nepalese authorities on Sunday confiscated 90 cargo containers loaded with products of Dabur Nepal bound for India from the Sirsiya dry port in Birgunj district.
- Read more about Let skin enjoy magical properties of cocoa, mulberry
Winter air affects our skin in several ways and makes it dry and itchy. This is when the magical properties of cocoa, banana and mulberry act best by moisturizing skin from deep within, say experts.
- Read more about Packaged food market to be worth $50 bn by 2017: Assocham
- Read more about Therapy linked to brain activity in personality disorder
A specialised psychotherapy has been linked to changes in activation patterns in certain areas of the brain in patients with borderline personality disorder (BPD), says a study, implying the treatment's impact may go deeper than symptom change.

[adsense:336x280:8701650588]
- Read more about Natco Pharma settled patent infringement with Gilead Sciences & others
Natco Pharma and Alvogen have settled the patent infringement suit filed by Gilead Sciences, Hoffmann-La Roche, F. Hoffmann-La Roche Ltd. and Genentech Inc. against them in New Jersey District Court.
- Read more about Suicide gene therapy kills prostate cancer cells
Combining radiation treatment with 'suicide gene therapy' - a technique in which prostate cancer cells are genetically modified so they signal a patient's immune system to attack them - provides an effective two-pronged punch against the disease, new research shows.
- Read more about 300 million child-friendly antimalarial treatments supplied without profit by Novartis
- Coartem® Dispersible*, the first WHO prequalified pediatric antimalarial treatment, has become the standard of care in over 30 malaria-endemic countries
- Since 2009, Novartis has supplied 300 million Coartem® Dispersible treatments without profit, mostly to the public sector, to treat children suffering from malaria
- Together with other innovations, Coartem® Dispersible contributed to reduce the malaria death rate by 71% for children under the age of 5 years
- Read more about Rhizen Pharmaceuticals entered license agreement with Novartis
Rhizen Pharmaceuticals have entered into an exclusive, worldwide license agreement, with Novartis for the development and commercialization of Rhizen’s, inhaled dual PI3K - delta gamma inhibitor and its closely related compounds for various indications.
- Read more about Sun Pharma collaborate for research with Israel & Spain
Sun Pharma entered into a tripartite research and option agreement with Israel-based Weizmann Institute of Science and Spain’s Health Research Institute of Santiago de Compostela (IDIS) to develop breakthrough products for the treatment of neurological diseases like brain stroke; as well as glioblastoma, a lethal brain cancer.
- Read more about FDA Advisory Committee Recommends Approval of Teva’s Asthma Biologic Reslizumab
Teva Pharmaceutical Industries Ltd announced that the U.S. Food and Drug Administration’s (FDA) Pulmonary-Allergy Drugs Advisory Committee recommended approval of reslizumab, a humanized anti-interleukin-5 (IL-5) IgG4K monoclonal antibody (mAb), in adult patients aged 18 years and older. Reslizumab is a targeted biologic therapy for the treatment of inadequately controlled asthma in patients with elevated blood eosinophils, despite an inhaled corticosteroid (ICS)-based treatment regimen.